Inogen Stock Based Compensation To Revenue from 2010 to 2024

INGN Stock  USD 9.78  0.40  4.26%   
Inogen Stock Based Compensation To Revenue yearly trend continues to be very stable with very little volatility. Stock Based Compensation To Revenue is likely to drop to 0.02. Stock Based Compensation To Revenue is a metric that compares the total value of stock-based compensation granted by Inogen Inc to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards. View All Fundamentals
 
Stock Based Compensation To Revenue  
First Reported
2010-12-31
Previous Quarter
0.02352848
Current Value
0.0181
Quarterly Volatility
0.01296767
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Inogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.9 M, Interest Expense of 6.4 M or Selling General Administrative of 79 M, as well as many indicators such as Price To Sales Ratio of 0.38, Dividend Yield of 0.0 or PTB Ratio of 0.59. Inogen financial statements analysis is a perfect complement when working with Inogen Valuation or Volatility modules.
  
Check out the analysis of Inogen Correlation against competitors.

Latest Inogen's Stock Based Compensation To Revenue Growth Pattern

Below is the plot of the Stock Based Compensation To Revenue of Inogen Inc over the last few years. It is a metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards. Inogen's Stock Based Compensation To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Inogen's overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation To Revenue10 Years Trend
Slightly volatile
   Stock Based Compensation To Revenue   
       Timeline  

Inogen Stock Based Compensation To Revenue Regression Statistics

Arithmetic Mean0.02
Geometric Mean0.01
Coefficient Of Variation61.48
Mean Deviation0.01
Median0.02
Standard Deviation0.01
Sample Variance0.0002
Range0.0374
R-Value0.64
Mean Square Error0.0001
R-Squared0.41
Significance0.01
Slope0
Total Sum of Squares0

Inogen Stock Based Compensation To Revenue History

2024 0.0181
2023 0.0235
2022 0.0326
2021 0.0306
2020 0.0266
2019 0.0252
2018 0.0357

About Inogen Financial Statements

Inogen investors utilize fundamental indicators, such as Stock Based Compensation To Revenue, to predict how Inogen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Stock Based Compensation To Revenue 0.02  0.02 

Pair Trading with Inogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inogen will appreciate offsetting losses from the drop in the long position's value.

Moving against Inogen Stock

  0.62VMD Viemed HealthcarePairCorr
  0.39DOCS DoximityPairCorr
  0.37CVS CVS Health Corp Aggressive PushPairCorr
  0.35FIGS Figs IncPairCorr
  0.35SSY SunLink Health SystemsPairCorr
The ability to find closely correlated positions to Inogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inogen Inc to buy it.
The correlation of Inogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock:
Check out the analysis of Inogen Correlation against competitors.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.873
Earnings Share
(2.25)
Revenue Per Share
14.095
Quarterly Revenue Growth
0.058
Return On Assets
(0.1)
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.